Physician

Abdallah Dlewati, M.D.

According to 2025 Medicare claims, Abdallah Dlewati, M.D. (NPI: 1609054899) practices endocrinology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is ENDOCRINE & DIABETES CONSULTANTS PC (NPI: 1144237082; TIN: 383595547) and primary practice location at 48309-3674. Dlewati is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Dlewati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 776 traditional Medicare patients, billed 2,387 HCPCS/CPT codes, and received $179,076 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,381 prescription claims across 768 beneficiaries totaling $3,221,373 in drug costs, led by Ozempic (Semaglutide). DME data shows 601 claims. Open Payments data shows 72 records totaling $1,490. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $929,440 to $3,221,373. For DME billing, reported payments moved sharply higher in recent years, from $4,014 to $160,870.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	974	4,341	$249,106
2016	926	3,889	$221,826
2017	911	4,321	$231,940
2018	892	3,859	$207,423
2019	974	4,364	$247,946
2020	848	3,323	$199,455
2021	864	3,612	$229,280
2022	813	2,985	$191,167
2023	772	2,882	$194,658
2024	776	2,387	$179,076

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	507	2,741	$929,440
2016	544	3,158	$1,164,968
2017	562	3,284	$1,364,416
2018	620	3,839	$1,742,803
2019	704	4,489	$2,184,718
2020	696	4,905	$2,378,105
2021	741	5,450	$2,882,261
2022	734	5,826	$3,499,277
2023	733	6,081	$3,895,035
2024	768	6,381	$3,221,373

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	200	486	$11,131
2016	231	472	$14,206
2017	226	411	$8,482
2018	260	637	$33,704
2019	282	724	$60,195
2020	243	735	$71,981
2021	246	816	$96,022
2022	221	905	$123,036
2023	198	921	$137,808
2024	171	601	$154,981

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	90	90	$126
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	168	179	$107
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	455	864	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	193	618	$65
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	128	366	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	472	27,496	$863,012
Jardiance	Empagliflozin	390	28,941	$538,560
Mounjaro	Tirzepatide	137	7,758	$273,614
Farxiga	Dapagliflozin Propanediol	129	9,450	$168,549
Tresiba Flextouch U-100	Insulin Degludec	130	12,204	$116,760

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	72	318	$142,915
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	16	$3,950
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	54	140	$3,506
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	14	14	$3,101
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	15	$1,287

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	72	$1,490	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdallah Dlewati, M.D.?

Tedicare shows public-source Medicare data for Abdallah Dlewati, M.D. (NPI 1609054899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah Dlewati, M.D. have ACO affiliation data?

Abdallah Dlewati, M.D. is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Abdallah Dlewati, M.D.?

Abdallah Dlewati, M.D. is linked to ENDOCRINE & DIABETES CONSULTANTS PC (billing NPI 1144237082) in the available physician profile data.

Does Abdallah Dlewati, M.D. have Open Payments data?

Abdallah Dlewati, M.D. has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.